We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

StemCells, Inc. Announces Closure of Enrollment in Phase I/II Dry AMD Trial

News   Jun 24, 2014

 
StemCells, Inc. Announces Closure of Enrollment in Phase I/II Dry AMD Trial
 
 
 

RELATED ARTICLES

Chemokine Maintains Dormancy of "Sleeper Stem Cells" in Leukemia Subtype

News

The mechanism behind the maintenance of leukemic stem cells in chronic myelogenous leukemia has become clearer, following a study that explored how niche-specific expression of a particular chemokine in a type of bone marrow controls quiesence.

READ MORE

Tissue-engineering Approach for Common Jaw Defect

News

Cells were taken from the rib cartilage of a Yucatan miniature pig, grown in a laboratory and implanted as a construct into a separate animal.

READ MORE

FDA Approves First Treatment for Postpartum Depression

News

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE